Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by narmacon Dec 27, 2022 12:08pm
172 Views
Post# 35192491

Hummmmmm,,,the reality is,,,,,

Hummmmmm,,,the reality is,,,,,Midatech is NOT buying out Bioasis,,,, this bovine excrement of a statement fostered by Midatech in its press releases should be rebutted at every instance by shareholders.,,,are we really considered to be that stupid by these management teams???

A consortium of venture capitalist investors are taking out both companies with one shot!!,,Sort of a  Robin Hood play!!,,,,only spoils wont be shared faifly as in the days of Mr. Hood!!, and management in both companies agree their assets and IP value is worth only a pittance!,,,,,,,,,,,,,, How things can change overnight!!!

The value in both has past for existing shareholders,, which was supported, bought and paid for by the existing shareholders with their out of pocket dollars!!,,the reaql value,, if any comes to fruition will be collected by the consortium!!!,,Not us!!!

The story never changed over the past decade,,it only got better which in effect netted more dollars from investors these past years. Pitiful all around!

So it must be clearly understood,,,,,,Biodexa managemnet will have no control in the business,,,they will do the science,,,,,certainly no control going forward as far as what if any profit existing shareholders might get,,,,,both companies will be owned by outside interests with each company having a poppers stake in the overall scheme of things!,,thats the facts,,and facts are important as we all know!!

Why vote at all is my question!!,,,everytime I see this bullboard my blodo pressure spikes!!


<< Previous
Bullboard Posts
Next >>